RENEE DONNELLY: Open Payments
NPI 1760797427 · PHILADELPHIA, PA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,363 in 56 payments from 28 companies in 2025. Trend: 2023 $36 · 2024 $99 · 2025 $1,363
Food & beverage: $1,295Education: $68
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 7 | $217 |
| Novartis Pharmaceuticals Corporation | 5 | $134 |
| Ipsen Biopharmaceuticals, Inc | 5 | $114 |
| Merck Sharp & Dohme LLC | 5 | $101 |
| Deciphera Pharmaceuticals Inc. | 3 | $69 |
| Karyopharm Therapeutics Inc. | 2 | $57 |
| PFIZER INC. | 2 | $54 |
| Daiichi Sankyo Inc. | 2 | $53 |
| Eisai Inc. | 2 | $48 |
| BeOne Medicines USA, Inc. | 2 | $47 |
Products named: Onivyde, TAGRISSO, KEYTRUDA, KISQALI, IMFINZI, XPOVIO, Enhertu, QINLOCK.
Industry payments across PA — which companies pay providers there.
